ReviewThe Lancet regional health. Western Pacific2025
Epidemiology of mature T-cell and NK-cell neoplasms: east and west.
Review in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Epidemiology and outcomes of invasive fungal infections in patients with mature T-cell and NK-cell lymphomas.Annals of medicine · 2026Article
- Focus on extranodal NK/T cell lymphomas.Leukemia · 2026Article
- EBV-Driven NK/T-Cell Lymphoproliferative Disorders: Clinical Diversity and Molecular Insights.Lymphatics · 2026Article
- Peripheral T-cell Lymphoma in Japan: Real-World Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs.Journal of health economics and outcomes research · 2026Article
- Multi-Omics Prioritization and Clinical Evaluation of CYP4V2 as a Candidate Biomarker in Venous Thromboembolism.International journal of general medicine · 2026Article
- Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics.Journal of personalized medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mature T-cell and natural killer (NK) cell lymphomas are uncommon. Their epidemiological data are mainly derived from Western and Eastern countries, some with significant variations. These differences may be related to genetic susceptibilities, prevalence of oncogenic viruses and other environmental factors. Nodal mature T-cell lymphomas are most common, with their incidences varying ethnically/geographically. Extranodal T-cell lymphomas have very different epidemiologic features. Adult T-cell leukaemia/lymphoma, due to human T-cell leukaemia virus type-1 (HTLV-1) infection, is found mainly in HTLV-1 endemic areas. Mycosis fungoides, the most common cutaneous T-cell lymphoma in the West, accounts for <2% of T-cell lymphomas in Asia. Epstein-Barr virus (EBV) related T-cell lymphomas are common in Asia and Central/South America but exceptional in the West. Germline polymorphisms of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.